Literature DB >> 12673440

Effect of nifedipine on the expression of bcl-2 protein in rat gingiva.

Juni Handajani1, A L Supartinah Santoso, Tetiana Haniastuti, Totok Utoro, Wihaskoro Sosroseno.   

Abstract

Bcl-2 is a family of proteins involved in protecting the cell against death stimuli or in promoting cell death. The aim of the present study was to determine the effect of nifedipine treatment on the expression of bcl-2 protein in rat gingival tissues. Rats were given gastric intubation with various concentrations and durations of nifedipine. Nifedipine-untreated and dimethylsulfoxide (DMSO)-treated animals served as control groups. The gingival tissues were dissected and the expression of bcl-2 protein was determined immunohistochemically. The results showed that the numbers of bcl-2-positive cells in the gingiva of nifedipine-treated animals were significantly higher than in the control groups. These numbers increased parallel to increased concentration and duration of nifedipine treatment. The results suggest that nifedipine treatment may induce the expression of bcl-2 protein in rat gingival tissue in a dose- and duration-dependent fashion and that this proto-oncogenic protein may play a role in nifedipine-induced gingival hyperplasia.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12673440     DOI: 10.1007/s00784-003-0194-7

Source DB:  PubMed          Journal:  Clin Oral Investig        ISSN: 1432-6981            Impact factor:   3.573


  10 in total

1.  Expression of p53 protein and Ki-67 antigen in gingival hyperplasia induced by nifedipine and phenytoin.

Authors:  K Saito; S Mori; N Tanda; S Sakamoto
Journal:  J Periodontol       Date:  1999-06       Impact factor: 6.993

2.  Keratinocyte growth factor is upregulated by the hyperplasia-inducing drug nifedipine.

Authors:  S J Das; I Olsen
Journal:  Cytokine       Date:  2000-10       Impact factor: 3.861

Review 3.  The Bcl-2 protein family: arbiters of cell survival.

Authors:  J M Adams; S Cory
Journal:  Science       Date:  1998-08-28       Impact factor: 47.728

4.  Novel primitive lymphoid tumours induced in transgenic mice by cooperation between myc and bcl-2.

Authors:  A Strasser; A W Harris; M L Bath; S Cory
Journal:  Nature       Date:  1990-11-22       Impact factor: 49.962

5.  Immunohistochemical localization of transforming growth factor beta, basic fibroblast growth factor and heparan sulphate glycosaminoglycan in gingival hyperplasia induced by nifedipine and phenytoin.

Authors:  K Saito; S Mori; M Iwakura; S Sakamoto
Journal:  J Periodontal Res       Date:  1996-11       Impact factor: 4.419

6.  Immunolocalizaiton of c-Myc and bcl-2 proto-oncogene products in gingival hyperplasia induced by nifedipine and phenytoin.

Authors:  K Saito; S Mori; N Tanda; S Sakamoto
Journal:  J Periodontol       Date:  2000-01       Impact factor: 6.993

Review 7.  A matter of life and cell death.

Authors:  G Evan; T Littlewood
Journal:  Science       Date:  1998-08-28       Impact factor: 47.728

8.  Cooperative interaction between c-myc and bcl-2 proto-oncogenes.

Authors:  A Fanidi; E A Harrington; G I Evan
Journal:  Nature       Date:  1992-10-08       Impact factor: 49.962

Review 9.  Nifedipine-induced gingival hyperplasia. A comprehensive review and analysis.

Authors:  M Harel-Raviv; M Eckler; K Lalani; E Raviv; M Gornitsky
Journal:  Oral Surg Oral Med Oral Pathol Oral Radiol Endod       Date:  1995-06

10.  Effect of nifedipine on the expression of p53 protein in rat gingiva.

Authors:  T Haniastuti; A Supartinah Santoso; P Agustiono; D Agustina; W Sosroseno
Journal:  Biomed Pharmacother       Date:  2002-07       Impact factor: 6.529

  10 in total
  1 in total

1.  Minichromosome maintenance 2 and 5 expressions are increased in the epithelium of hereditary gingival fibromatosis associated with dental abnormalities.

Authors:  Hercílio Martelli-Júnior; Carolina de Oliveira Santos; Paulo Rogério Bonan; Paula de Figueiredo Moura; Carolina Cavalcante Bitu; Jorge Esquiche León; Ricardo D Coletta
Journal:  Clinics (Sao Paulo)       Date:  2011       Impact factor: 2.365

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.